Brief: Diagnos announces one-year agreement in North Africa with major pharma co
24/10/2017 14:01
Oct 24 (Reuters) - Diagnos Inc ADK.V
* Diagnos announces a one-year agreement in North Africa
with a major pharmaceutical company after successful pilot
* Diagnos Inc - positive conclusion to a pilot project by
signing a Turnkey one-year screening contract in North Africa
Source text for Eikon: ID:nMKWLrWMNa
Further company coverage: ADK.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Diagnos
See all newsBrief: Diagnos Submits Modified And Updated Health Canada Licence Application For Cara System Platform
Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
Brief: Diagnos Welcomes Dr. Pierre-Luc Charlebois To Its Advisory Board
Brief: Validated For Global Scale Diagnos Passes Annual MDSAP Audit, Solidifying The Pathway To Approvals With Health Canada & FDA
Brief: Diagnos Provides Update On Its Health Canada Medical Device Licence Application